Guangdong Intelligent Health Industry Co., Ltd. is a medical data technology company, currently set up branches in Hong Kong, Shanghai, Changsha and Chongqing, the core team has been focusing on female "two cancer screening" for 20 years, in 2000 became the Chinese general agent of Hologic Corporation Thinprep TCT (Thinprep), in 2005 became the South China general representative of Roche HPV detection system in the United States, helping Chinese doctors to open a cervical lesion specialty from scratch, opening a new era of cervical cancer prevention and treatment in China He has rich practical experience in the field of early cancer screening.

In 2015, the company that represented the new Thinprep TCT (Thinprep) products of Hologic was acquired by Hologic.

In 2016~2019, Guangzhou Fan'an Medical, established by the core team, built a family doctor signing platform for the Guangzhou Municipal Government: Community Good E-students, helping Guangzhou to complete the family doctor signing and chronic disease management of 18 million residents.

In 2019, Intelligent Health once again successfully introduced Russia's global patented technology - MEIK electrical impedance (EIT) breast scanning digital imaging detection system, which has completed clinical verification in Chaoyang Hospital affiliated to Capital Medical University, Beijing Third Hospital, Guangdong Provincial People's Hospital, Guangdong Province Maternal and Children, Guangzhou Maternal and Child and other well-known hospitals, which is the designated technology of China Primary Health Care Foundation to support county medical care, and has become the breast cancer screening technology designated by the Guangdong Provincial Federation of Trade Unions. Joined hands with Chinese Health Insurance Company to conduct breast cancer screening for female employees in Guangdong Province, opening a new era of digital breast health management.

Intelligent Health has more than 20 years of expertise in the application of health information technology, electronic medical records and commercialization of medical films, especially in chronic disease management, remote monitoring and wearable devices, providing innovative and unique intelligent medical solutions for the Chinese government and people. In the future, we will continue to deepen the globalization strategy of products, channels, services and supply chains, and work with the world's leading partners in new technologies such as Internet of Things, artificial intelligence, and big data that meet China's national conditions to provide reliable support for medical communityization and family health, so as to effectively prevent diseases, improve the quality of health management and alleviate the pressure on medical resources, and accelerate the intelligent development of China's medical and health industry.